Skip to main content
logo
Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)
South Korea flag South Korea · Delayed Price · Currency is KRW
72,600
-1,400 (-1.89%)
Sep 10, 2026, 9:15 AM KST

Mezzion Pharma Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
40,30825,57413,61740,24629,39924,210
Short-Term Investments
0-15,00018,0003,00023,284
Cash & Short-Term Investments
40,30825,57428,61758,24632,39947,494
Cash Growth
7.35%-10.63%-50.87%79.78%-31.78%-3.28%
Accounts Receivable
1,0251,078869.932,3092,6442,368
Other Receivables
287.91202.26457.472,154238.76377.57
Receivables
2,1831,9901,7575,9254,2034,435
Inventory
5,3015,3025,4205,7428,83511,777
Prepaid Expenses
215.48113.77127.5136.44265.05266.77
Other Current Assets
10,06012,6066,0044,194195.28201.3
Total Current Assets
58,06845,58641,92674,24445,89764,174
Property, Plant & Equipment
2,1902,5162,5292,8544,2454,879
Long-Term Investments
003.087.46--0
Other Intangible Assets
1,6201,6201,6201,6201,6201,620
Long-Term Deferred Charges
62,61547,49826,82011,324-12,559
Other Long-Term Assets
656.17694.49821.11,9511,950672.93
Total Assets
125,24998,02573,99892,14954,02283,935

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
2,1041,8101,6464,0307,1735,503
Accrued Expenses
28,39023,69218,88221,831-7,188
Short-Term Debt
15,5839,910-499.581,063932.01
Current Portion of Leases
841.34812.5694.38735.87-1,051
Current Income Taxes Payable
--3,892---
Other Current Liabilities
38,20943,3491,5562,51917,8443,823
Total Current Liabilities
85,12879,57226,67029,61526,08018,497
Long-Term Leases
891.31,151921.471,005-2,338
Pension & Post-Retirement Benefits
77.78----217.2
Long-Term Deferred Tax Liabilities
--251.42---
Other Long-Term Liabilities
107.26106.6291.9884.611,70289.78
Total Liabilities
86,20480,83027,93530,70527,78221,141

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
15,30315,18214,98214,80413,3714,451
Additional Paid-In Capital
189,419173,602159,062150,51099,256107,802
Retained Earnings
-175,793-178,129-143,148-123,723-111,052-74,789
Comprehensive Income & Other
10,1156,53915,16719,85424,66525,330
Shareholders' Equity
39,04417,19546,06361,44426,24062,793
Total Liabilities & Equity
125,24998,02573,99892,14954,02283,935

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
17,31611,8731,6162,2411,0634,321
Net Cash (Debt)
22,99213,70127,00156,00631,33643,173
Net Cash Growth
-16.54%-49.26%-51.79%78.73%-27.42%-1.88%
Net Cash Per Share
757.17454.88905.271983.281172.201617.75
Filing Date Shares Outstanding
30.3830.3629.9629.6126.7426.7
Total Common Shares Outstanding
30.3830.3629.9629.6126.7426.7
Working Capital
-27,060-33,98715,25544,62819,81745,678
Book Value Per Share
1285.33566.281537.302075.31981.232351.55
Tangible Book Value
37,42515,57544,44359,82524,62061,174
Tangible Book Value Per Share
1232.00512.941483.242020.60920.662290.89
Buildings
----23.9723.97
Machinery
-2,1832,1911,9763,5232,908
Construction In Progress
---619.69439.17193.43